This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Staphylococcus aureus Sortase A (srtA)
Product Overview
BioVenic's Recombinant Staphylococcus aureus Sortase A (srtA) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 18.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Staphylococcus aureus sortase A (srtA) is a transpeptidase enzyme that mediates the covalent attachment of surface proteins to the bacterial cell wall, which is crucial for bacterial adhesion, immune evasion, and virulence. In veterinary medicine, Sortase A plays a significant role in the pathogenesis of infections caused by S. aureus in animals, contributing to the formation of biofilms and resistance to host immune responses. It is also a target for the development of novel anti-infective strategies, including vaccines and inhibitors that could prevent the attachment of S. aureus to host tissues, thereby reducing the severity of infections.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.